Optimizing Midlife Women’s Health: A Multidisciplinary Approach

As the US population undergoes significant demographic changes, midlife women are becoming an increasingly important group served by healthcare professionals. This necessitates a comprehensive understanding of the diverse medical concerns affecting women during this stage of life. The Midlifewomen’s Health 2023 educational activity aims to provide a multidisciplinary approach to caring for menopausal women, addressing the challenges posed by rapidly advancing research, technology, and pharmacology.

Expert clinicians from Massachusetts General Hospital will present on a range of topics, including:

• Evaluation and management of mood disorders
• Cancer survivorship and lifestyle medicine
• Skin health and available treatment options
• Recurrent urinary tract infections (UTIs) in aging women
• Obesity management through behavioral and pharmacologic strategies
• Cardiovascular health and digital innovation
• Transgender medicine and early menopause
• Menopausal hormone therapy, including novel non-hormonal options for hot flashes

Target Audience

This educational activity is designed for:

• Physicians and advanced practice nurses in primary care
• Gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine
• Physicians and advanced practice nurses in-training

Learning Objectives

Upon completion of this activity, participants will be able to:

• Formulate strategies to optimize care for cancer survivors after menopause
• Evaluate and treat recurrent UTIs in aging women
• Integrate digital innovation to improve cardiovascular health outcomes in midlife women
• Recognize midlife mood disorders and optimize care
• Utilize behavioral and pharmacologic strategies to manage obesity at midlife
• Integrate education and strategies to optimize the perimenopausal transition
• Assess a midlife woman’s risk of skin aging and guide her in utilizing available treatment options
• Utilize NK3-receptor antagonists as a novel and effective treatment for hot flashes once available
• Evaluate symptomatic midlife women for menopausal hormone therapy, incorporating an individualized assessment of risks and benefits

Program Schedule

Friday, May 12, 2023:

• 7:45 a.m. – Welcome & Introductory Remarks (Jan Shifren, MD, NCMP)
• 8:00 a.m. – Cancer Survivorship & Lifestyle Medicine (Amy Comander, MD)
• 8:45 a.m. – Transgender Medicine at Midlife (Jenny Siegel, MD)
• 9:30 a.m. – Recurrent UTIs in Aging Women: Evaluation & Management (May Wakamatsu, MD, Jacob Lazarus, MD, PhD)
• 10:15 a.m. – BREAK
• 10:30 a.m. – Digital Innovation for Improving Cardiovascular Health Outcomes in Midlife Women (Kaavya Paruchuri, MD)
• 11:15 a.m. – Managing Midlife Mood Mayhem (Marlene Freeman, MD)
• 12:00 p.m. – LUNCH BREAK
• 1:00 p.m. – Pharmacologic Treatment Options of Obesity (Klara Rosenquist, MD)
• 1:45 p.m. – Early Menopause: Strategies to Reduce Risk (Carey York-Best, MD)
• 2:30 p.m. – Keeping Skin Healthy as the Clock Ticks (Sandy Tsao, MD)
• 3:15 p.m. – BREAK
• 3:30 p.m. – Keynote Presentation: NK3-R Antagonists: Novel & Effective Treatment for Hot Flashes (Susan Reed, MD, MPH)
• 4:15 p.m. – Everything You Wanted to Know About Hormone Therapy, But Were Afraid to Ask